Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1464020

registered interest
date	18/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the 2016 Review on Antimicrobial Resistance: Lord O’Neill’s independent review of antimicrobial resistance in collaboration with the Wellcome Trust, which recommended that all antibiotic prescribing should be informed by rapid diagnostics, what steps he is taking to ensure that primary care settings are equipped with point of care multiplex testing technology.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	4632
answer	answer is ministerial correction date of answer 26/05/2022 answer text <p>As part of the United Kingdom’s national action plan for antimicrobial (AMR) resistance, NHS England and NHS Improvement’s AMR programme is examining the adoption of innovations in diagnostics, improving clinical best practice and applying point-of-care testing for urinary tract infections, respiratory tract infections, surgical site infections and acute deterioration, including sepsis.</p><p>This aims to identify any gaps in diagnostic pathways and practices with a focus on improving patient outcomes and antimicrobial stewardship in National Health Service and community care settings. Optimising the potential use of point-of-care multiplex testing in primary care is also being considered. NHS England and NHS Improvement supports the appointment of diagnostics and antimicrobial stewardship leads in each regional team in England. Additionally, national guidelines and national toolkits such as TARGET in primary care and ‘Start SMART then focus’ in secondary care, support antimicrobial stewardship, including the appropriate use of diagnostic tests and tools.</p><p><strong> </strong></p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 4630 4631 question first answered 26/05/2022 15:36:52 answering member 4447 label Biography information for Maggie Throup
tabling member	4474 label Biography information for Kevin Hollinrake

1464023

registered interest
date	18/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the report published by his Department entitled Tackling antimicrobial resistance 2019–2024: the UK's 5-year national action plan, published on 24 January 2019, whether his Department is taking steps to (a) tackle the growing threat of antimicrobial resistance and (b) embed support for antimicrobial stewardship in his Department's work.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	4633
answer	answer is ministerial correction date of answer 26/05/2022 answer text <p>The United Kingdom’s antimicrobial national action plan aims to reduce the need for and unintentional exposure to antimicrobials by lowering the burden of infection; optimise the use of antimicrobials; and invest in innovation, supply and access of new diagnostics, therapies and vaccines.</p><p>Diagnostics and antimicrobial stewardship leads have been appointed in NHS England regional teams and national toolkits, decision aids and guidelines to support the appropriate use of antimicrobials have been developed and published. Commissioning for Quality and Innovation schemes for management of urinary tract infection and reducing antimicrobial use in secondary care have also been implemented.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 26/05/2022 14:59:51 answering member 4447 label Biography information for Maggie Throup
tabling member	4474 label Biography information for Kevin Hollinrake

997217

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 March 2018 to Question 132264 on Antibiotics: Drug Resistance, whether his Department has made an assessment of the potential merits of including (a) the latest electronic technology to reduce hospital infections and (b) other best practice on hand hygiene compliance in the prevention strand of the new antimicrobial resistance strategy.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	185000
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>Infection prevention and control will remain a key pillar of the United Kingdom’s upcoming five-year national action plan on antimicrobial resistance.</p><p> </p><p>NHS Improvement, who lead on infection prevention and control, has included a hand hygiene monitoring and compliance workstream in its current work programme.</p><p> </p><p>NHS Improvement has undertaken a rapid review of evidence on the use of electronic monitoring devices across the National Health Service to determine hand hygiene compliance. The technology used in some trusts is currently reliant on local data infrastructure and many existing systems would not be able to support it.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 15:31:20 answering member 4067 label Biography information for Steve Brine
tabling member	4474 label Biography information for Kevin Hollinrake

861115

registered interest
date	13/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when his Department plans to publish a new five year AMR Strategy, and whether that strategy will include best practice on infection prevention and control, including hand hygiene compliance.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	132264
answer	answer is ministerial correction date of answer 16/03/2018 answer text <p>The current five year United Kingdom Antimicrobial Resistance (AMR) strategy was published at the end of 2013. Work is underway to consider the priorities and focus for a refreshed strategy and national action plan for publication at the end of 2018. The refreshed strategy will continue to focus on preventing infections as one of its key pillars.</p><p> </p><p>The current AMR programme has an ambition to halve healthcare associated Gram–negative blood stream infections by 2020/2021. NHS Improvement leads this work and has included hand hygiene in its work programme for 2018/19 in support of the ambition. As part of our work on the refreshed strategy, we will consider how to make best use of evidence-based and cost-effective technology.</p><p> </p><p>We are working with our partners across the health and social care system, including the Care Quality Commission, to ensure that consideration of best practice in hand hygiene policies remains a focus of inspections in acute trusts.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 132266 question first answered 16/03/2018 11:42:43 answering member 4067 label Biography information for Steve Brine
tabling member	4474 label Biography information for Kevin Hollinrake

861117

registered interest
date	13/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve hand hygiene compliance in hospitals to tackle antimicrobial resistance; and what assessment his Department has made of the potential merits of using health technology to improve such compliance.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	132266
answer	answer is ministerial correction date of answer 16/03/2018 answer text <p>The current five year United Kingdom Antimicrobial Resistance (AMR) strategy was published at the end of 2013. Work is underway to consider the priorities and focus for a refreshed strategy and national action plan for publication at the end of 2018. The refreshed strategy will continue to focus on preventing infections as one of its key pillars.</p><p> </p><p>The current AMR programme has an ambition to halve healthcare associated Gram–negative blood stream infections by 2020/2021. NHS Improvement leads this work and has included hand hygiene in its work programme for 2018/19 in support of the ambition. As part of our work on the refreshed strategy, we will consider how to make best use of evidence-based and cost-effective technology.</p><p> </p><p>We are working with our partners across the health and social care system, including the Care Quality Commission, to ensure that consideration of best practice in hand hygiene policies remains a focus of inspections in acute trusts.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 132264 question first answered 16/03/2018 11:42:43 answering member 4067 label Biography information for Steve Brine
tabling member	4474 label Biography information for Kevin Hollinrake

714582

registered interest
date	28/03/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he expects the Global Antimicrobial Resistance Innovation Fund to be open to research applications for the repurposing of antibiotics.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	69526
answer	answer is ministerial correction date of answer 05/04/2017 answer text <p>The Government has committed £50 million towards setting up a Global Antimicrobial Resistance (AMR) Innovation Fund to increase global investment in AMR. The fund aims to leverage substantial new international investment in AMR research and development for new and repurposed antimicrobials and alternative medicines, rapid diagnostic tests, vaccines and other important technologies, interventions and therapies.</p><p>Professor Dame Sally Davies, the Chief Medical Officer for England and United Kingdom Government adviser, has appointed an expert advisory board to make recommendations on the scope and focus of the investment.</p><p>These discussions are ongoing.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 05/04/2017 10:00:27 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4474 label Biography information for Kevin Hollinrake

714584

registered interest
date	28/03/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he expects the first pilots of the Global Antimicrobial Resistance Innovation Fund on reimbursement models to incentivise the development of new classes of antibiotics to begin.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	69527
answer	answer is ministerial correction date of answer 05/04/2017 answer text <p>The Global Antimicrobial Resistance (AMR) Innovation Fund is a £50 million investment over five years to tackle AMR, with the aim of attracting significant additional investment internationally to stimulate global research. It is not looking at reimbursement models to incentivise the development of new classes of antibiotics or planning to fund pilots at this stage.</p><p>Domestically, the Department is working with the National Institute for Health and Care Excellence and the Association of the British Pharmaceutical Industry to develop a new reimbursement model for antimicrobials, and has secured broad agreement to principles that would permit a model to ‘de-link’ company revenues from sales. The aim of this work is to support good antimicrobial stewardship. Discussions with a number of leading pharmaceutical companies have highlighted challenges in evaluating antimicrobial medicines, and the Department is working closely with industry partners to address these.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 05/04/2017 10:24:11 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4474 label Biography information for Kevin Hollinrake

536471

registered interest
date	14/07/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what role he plans for the UK in discussing antimicrobial resistance at the G20 summit in September 2016.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	42800
answer	answer is ministerial correction date of answer 19/07/2016 answer text <p>Antimicrobial resistance (AMR) is growing, presenting huge costs to both society and the global economy – it is estimated that AMR will have a cumulative cost of $100 trillion by 2050. One of the main issues driving the increase in AMR is a market failure preventing enough new antibiotic drugs from getting to market. The United Kingdom sees the G20 as the best forum to discuss this economic issue and take action. The UK is calling for the G20 to look at how it can put in place innovative financing mechanisms to reinvigorate the antimicrobial development pipeline and help rectify this market failure.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 19/07/2016 13:46:45 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4474 label Biography information for Kevin Hollinrake